J. Simon

Workgroup III: facilitating screening for colorectal cancer: quality assurance and evaluation. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002).

D. Ransohoff, E. Weiderpass, G. Hoff, 2005, Annals of Oncology.

Long-term disease-free survivors in metastatic undifferentiated carcinoma of nasopharyngeal type.

J. Armand, F. Eschwège, H. Boussen, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A randomised phase II study of oxaliplatin alone versus oxaliplatin combined with 5-fluorouracil and folinic acid (Mayo Clinic regimen) in previously untreated metastatic colorectal cancer patients.

M. Vilanova, E. Cazap, G. Recondo, 2001, European journal of cancer.

Factors predicting for efficacy of oxaliplatin in combination with 5-fluorouracil (5-FU)+/-folinic acid (FA) in a compassionate-use cohort of 370 5-FU-resistant advanced colorectal cancer (CRC) patients.

M. Ducreux, F. Lévi, M. Marty, 2000, European journal of cancer.

Is there a relationship between colorectal and prostate cancer?

W. Longo, J. Simon, Anthony Vemava, 1994, Diseases of the colon and rectum.

Relationship between colorectal and prostate cancer

A. Vernava, A. Spigelman, W. Longo, 1995, Diseases of the Colon & Rectum.